Still reeling from cyberattack, Merck warns some drug supplies may be delayed
admin 28th July 2017 Uncategorised 0Merck & Co., one of the victims of the Petya cyberattack last month, has yet to fully restore its manufacturing and R&D operations since they were hit more than four weeks ago. The attack and its costs didn’t hit its second-quarter numbers, but they’re an unexpected blow to Merck’s prospects for the rest of the year.
More: Still reeling from cyberattack, Merck warns some drug supplies may be delayed
Source: fierce